Cardiac Insight, Inc. Secures First Cardiology Customers for Its Wearable ECG Sensor, Cardea SOLO™

Cardea SOLO Device and Software Analysis System Confirmed to Simplify
and Enhance Patient Experience, Cardiac Arrhythmia Data Reporting and
Time-to-Diagnosis and Treatment

KIRKLAND, Wash.–(BUSINESS WIRE)–#AFib–Cardiac Insight, Inc., a U.S. developer of wearable medical devices and
diagnostic software, announced today that the company has secured its
first cardiology customers for its wearable ECG sensor device, Cardea
SOLO, in Texas and several other states. Early physician and patient
experiences with Cardea SOLO are confirming the FDA-cleared cardiac
device, designed to streamline arrhythmia detection in patients, is
providing a higher standard of ambulatory cardiac care and efficiencies
in cardiac practices.

“Cardiology Partners is focused on bringing the best and most
sophisticated cardiology care to our community and patients. Cardea
SOLO’s superior approach to arrhythmia reporting and monitoring is
contributing to this goal,” said Dr. James Richardson, cardiologist and
partner in Cardiology Partners with clinics in Mansfield and Arlington,
Texas.

“Lives and costs can be saved with our advanced ECG solution. Cardea
SOLO brings capabilities and benefits no other wearable cardiac
monitoring technology can offer when it comes to ambulatory arrhythmia
diagnosis,” said Brad Harlow, Co-Founder and Chief Executive Officer,
Cardiac Insight, Inc.

Harlow claims the growing interest in the company’s flagship product
Cardea SOLO, a 7-day wearable ECG sensor and unique arrhythmia detection
software, is due to the convergence of the most desirable benefits now
available in a single monitoring system:

• Cardea SOLO’s compact, cable-free ECG device records every heart beat,
  yet offers longer, comfortable and nonintrusive diagnostic wear time
  that improves a patient’s experience and compliance, especially when
  compared to a traditional 48-hour ECG monitor.
• Its standalone plug-and-play ECG arrhythmia analysis and reporting
  system seamlessly integrates into a cardiology or other medical
  clinic’s existing operational infrastructure, keeping patient data
  secure and available immediately for review.

Cardea SOLO is small, lightweight (about the weight of three quarters),
water-resistant and single-use disposable. Richardson said his patients
like how easy it is to wear and how quickly they can receive their
cardiac report results, which can relieve concerns about symptoms or can
shorten time to needed treatment.

“Our patients comment that Cardea SOLO feels more like a stick-on
bandage rather than a cumbersome cardiac monitoring device with wires,
or one that requires extended wear time and typically takes longer to
get test results,” said Richardson. “With Cardea SOLO, patients can come
to our clinic, have the device, which we keep stocked on site, quickly
applied and then go about their regular activities while wearing it.
Because Cardea SOLO is durable and unobtrusive, it increases the
likelihood patients will wear the device, improving compliance and our
ability to capture actionable patient data for diagnosis.”

Bob Odell, Chief Operating Officer of Cardiac Insight, added that Cardea
SOLO is the only single-lead, cable-free ECG wearable with a
Windows®-based software analysis system that can produce a concise and
full-disclosure report of findings for immediate clinician review –
right in the doctor’s office. “Cardea SOLO can trim days or weeks off
the previously required cardiac data cycle time needed with
third-parties involved,” said Odell.

“The device and system puts the cardiology data in our hands in a
timely, comprehensive and secure manner and raises our level of
capabilities above other practices,” said Richardson. “Because Cardea
SOLO empowers us with more efficient and enhanced reporting within our
clinics and practices, we can provide increased 1:1 interaction with
patients. That can only mean immediate and long-term benefits for all
involved.”

In September, Cardiac Insight announced another infusion of investment
into its active C-1 funding round and development of a Scientific
Advisory Board.

Cardea SOLO is available by contacting solo@cardiacinsightinc.com.

About Cardiology Partners:

The physicians, nurses and medical assistants of Cardiology Partners (www.cardiologypartners.com)
have been providing exceptional cardiac care for patients in the
Mansfield/Arlington, Texas area since 1979. As the largest cardiology
practice in Mansfield, Cardiology Partners offers comprehensive and
compassionate patient care with a wide range of in-office treatment
options and privileges at all major hospitals in the Mansfield/Arlington
area. The practice combines physicians trained in the latest
advancements in treatment options with the extensive experience and
expertise of the founding partners to bring the most sophisticated care
to their patients.

About Cardiac Insight:

Cardiac Insight, Inc. (www.cardiacinsightinc.com)
is a U.S. developer of advanced body-worn digital health care
information devices for cardiology, respiratory and other complex
disease states. The company’s technologies and systems are created using
advanced algorithms and software that provide improvements in mean time
to diagnosis. Cardiac Insight’s mission is to invent complete and
progressive solutions for unmet clinical needs on behalf of physicians,
clients and payers. Cardiac Insight was founded in 2008 and is based in
Kirkland, WA.

Contacts

For Cardiac Insight, Inc.
Teresa Fausti, 425-503-5674
teresa@fausticommunications.com